(Q40589441)

21 September 2017

1 reference

title

Cytokine-mediated gene therapy for cancer (English)

1 reference

21 September 2017

0 references

A R Miller

1

1 reference

21 September 2017

W H McBride

series ordinal

2

1 reference

21 September 2017

K Hunt

series ordinal

3

1 reference

21 September 2017

J S Economou

series ordinal

4

1 reference

21 September 2017

publication date

1 September 1994

1 reference

Annals of Surgical Oncology

21 September 2017

published in

1 reference

21 September 2017

volume

1

1 reference

21 September 2017

issue

5

1 reference

21 September 2017

page(s)

436-450

1 reference

B-cell stimulatory factor-1/interleukin 4.

21 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02303818

The panspecific hemopoietin of activated T lymphocytes (interleukin-3).

21 January 2018

1 reference

12 December 2020

Role of the major histocompatibility complex class I antigens in tumor growth and metastasis

1 reference

12 December 2020

Comparative antiproliferative activity in vitro of natural interferons alpha and beta for diploid and transformed human cells.

1 reference

12 December 2020

A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability

1 reference

12 December 2020

Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review

1 reference

12 December 2020

Antitumor activity of recombinant interleukin 6 in mice

1 reference

12 December 2020

Interleukin 4 mediates autocrine growth of helper T cells after antigenic stimulation.

1 reference

12 December 2020

IL-4 down-regulates IL-1 and TNF gene expression in human monocytes

1 reference

12 December 2020

Characteristics of interleukin-6-enhanced lymphokine-activated killer cell function

1 reference

12 December 2020

Reduced tumorigenicity of fibrosarcomas which constitutively generate IL-1 alpha either spontaneously or following IL-1 alpha gene transfer

1 reference

12 December 2020

Immunization of cancer patients using autologous cancer cells modified by insertion of the gene for interleukin-2

1 reference

12 December 2020

Fibrosarcoma cells transduced with the IL-6 gene exhibited reduced tumorigenicity, increased immunogenicity, and decreased metastatic potential

1 reference

12 December 2020

Interleukin 7 induces CD4+ T cell-dependent tumor rejection

1 reference

12 December 2020

Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-alpha

1 reference

12 December 2020

B cell stimulatory factor 1 (IL-4) enhances the development of cytotoxic T cells from Lyt-2+ resting murine T lymphocytes.

1 reference

12 December 2020

An eosinophil-dependent mechanism for the antitumor effect of interleukin-4

1 reference

12 December 2020

Interleukin-1 production by transformed fibroblasts. II. Influence on antigen presentation and T-cell-mediated anti-tumor response

1 reference

12 December 2020

Interleukin 4 potentiates the antiproliferative effects of tumor necrosis factor on various tumor cell lines

1 reference

12 December 2020

Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells

1 reference

12 December 2020

Tumors secreting human TNF/cachectin induce cachexia in mice

1 reference

12 December 2020

Induction of intercellular adhesion molecule 1 on small cell lung carcinoma cell lines by gamma-interferon enhances spontaneous and bispecific anti-CD3 x antitumor antibody-directed lymphokine activated killer cell cytotoxicity

1 reference

12 December 2020

In vivo evaluation of the effects of interleukins 2, 4 and 7 on enhancing the immunotherapeutic efficacy of anti-tumor cytotoxic T lymphocytes

1 reference

12 December 2020

Transduction of human melanoma cell lines with the human interleukin-7 gene using retroviral-mediated gene transfer: comparison of immunologic properties with interleukin-2.

1 reference

12 December 2020

Tumor necrosis factor: a potent effector molecule for tumor cell killing by activated macrophages

1 reference

12 December 2020

Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients

1 reference

12 December 2020

1 reference

12 December 2020

A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance

1 reference

12 December 2020

Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo

1 reference

12 December 2020

Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells

1 reference

12 December 2020

Retrovirus vectors: promise and reality

1 reference

12 December 2020

Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk.

1 reference

12 December 2020

Gene Transfer In Vivo with DNA–Liposome Complexes: Safety and Acute Toxicity in Mice

1 reference

12 December 2020

Transduction of a foreign histocompatibility gene into the arterial wall induces vasculitis

1 reference

12 December 2020

Modulation of the tumorigenicity of human adenovirus-12-transformed cells by interferon.

1 reference

12 December 2020

Production of interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor by human mononuclear cells stimulated with granulocyte-macrophage colony-stimulating factor

1 reference

12 December 2020

Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2

1 reference

12 December 2020

Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells

1 reference

12 December 2020

Activation of antibody-dependent cell-mediated cytotoxicity of human neutrophils and eosinophils by separate colony-stimulating factors

1 reference

12 December 2020

Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors

1 reference

12 December 2020

Long-term inhibition of tumor growth by tumor necrosis factor in the absence of cachexia or T-cell immunity

1 reference

12 December 2020

Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer

1 reference

12 December 2020

Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody

1 reference

12 December 2020

Direct antiproliferative effects of recombinant human interferon-alpha B/D hybrids on human tumor cell lines

1 reference

12 December 2020

Expression of murine interleukin 7 in a murine glioma cell line results in reduced tumorigenicity in vivo

1 reference

12 December 2020

Immunotherapy of malignancy by in vivo gene transfer into tumors

1 reference

12 December 2020

Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells

1 reference

12 December 2020

Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo

1 reference

12 December 2020

Transfection of interleukin 2 gene into human melanoma cells augments cellular immune response.

1 reference

12 December 2020

Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity

1 reference

12 December 2020

Regulation of cytolytic T-lymphocyte generation by B-cell stimulatory factor.

1 reference

12 December 2020

Interleukin 6: a fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression

1 reference

12 December 2020

Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma

1 reference

12 December 2020

The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity

1 reference

12 December 2020

IL-6/IFN-beta-2 as a circulating hormone. Induction by cytokine administration in humans

1 reference

12 December 2020

Immunotherapy with cytokine gene-transduced tumor cells: the next wave in gene therapy for cancer

1 reference

12 December 2020

Clinical toxicity of interferons in cancer patients: a review

1 reference

12 December 2020

Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity

1 reference

12 December 2020

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

12 December 2020

HLA-class-I and -class-II expression on renal tumor xenografts and the relation to sensitivity for alpha-IFN, gamma-IFN and TNF.

1 reference

12 December 2020

Influence of tumor-derived interleukin 1 on melanoma-endothelial cell interactions in vitro

1 reference

12 December 2020

Treatment of malignant carcinoid tumors: a randomized controlled study of streptozocin plus 5-FU and human leukocyte interferon

1 reference

12 December 2020

Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells

1 reference

12 December 2020

Overview of biological response modifiers

1 reference

12 December 2020

Interleukin-4 downregulates interleukin-6 production in human peripheral blood mononuclear cells

1 reference

12 December 2020

1 reference

12 December 2020

Cytokine secretion by genetically modified nonimmunogenic murine fibrosarcoma. Tumor inhibition by IL-2 but not tumor necrosis factor

1 reference

12 December 2020

Administration of recombinant IL-4 to humans regulates gene expression, phenotype, and function in circulating monocytes

1 reference

12 December 2020

Cachectin/tumour necrosis factor

1 reference

12 December 2020

Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells

1 reference

12 December 2020

Interleukin 3 enhances development of tumor-reactive cytotoxic cells by a CD4-dependent mechanism

1 reference

12 December 2020

Immunization of cancer patients using autologous cancer cells modified by insertion of the gene for tumor necrosis factor

1 reference

12 December 2020

Implantation of fibroblasts transfected with human granulocyte colony-stimulating factor cDNA into mice as a model of cytokine-supplement gene therapy

1 reference

12 December 2020

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

1 reference

12 December 2020

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression

1 reference

12 December 2020

Genetic modification of a murine fibrosarcoma to produce interleukin 7 stimulates host cell infiltration and tumor immunity

1 reference

12 December 2020

Tumor necrosis factors alpha and beta differ in their capacities to generate interleukin 1 release from human endothelial cells

1 reference

12 December 2020

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

1 reference

12 December 2020

Immunotherapy and gene therapy of cancer

1 reference

12 December 2020

Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist

1 reference

12 December 2020

Interleukin-1 and interleukin-1 antagonism

1 reference

12 December 2020

Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines

1 reference

12 December 2020

Retroviral-mediated gene transfer

1 reference

12 December 2020

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

1 reference

12 December 2020

1 reference

12 December 2020

Immunotherapy of cancer using local administration of lymphoid cells transformed by IL-2 cDNA and constitutively producing IL-2

1 reference

12 December 2020

The clinical use of colony stimulating factors

1 reference

12 December 2020

Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells

1 reference

12 December 2020

Development of adenovirus vectors for the expression of heterologous genes

1 reference

12 December 2020

Interleukin-1 stimulates proliferation of acute myeloblastic leukemia cells by induction of granulocyte-macrophage colony-stimulating factor release

1 reference

12 December 2020

Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins

1 reference

12 December 2020

Use of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells

1 reference

12 December 2020

Lack of tumorigenicity of interleukin 4 autocrine growing cells seems related to the anti-tumor function of interleukin 4.

1 reference

12 December 2020

Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1)

1 reference

12 December 2020

Cloning and expression of murine IL-12

1 reference

12 December 2020

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

12 December 2020

Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene.

1 reference

12 December 2020

IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells

1 reference

12 December 2020

Interleukin-6: an overview

1 reference

12 December 2020

The dendritic cell system and its role in immunogenicity

1 reference

12 December 2020

Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro

1 reference

12 December 2020

Pathogenesis of fever

1 reference

12 December 2020

Tumor necrosis factors: gene structure and biological activities

1 reference

12 December 2020

Enhancement of metastatic potential by gamma-interferon.

1 reference

12 December 2020

Alpha 1-interferon gene transfer into metastatic Friend leukemia cells abrogated tumorigenicity in immunocompetent mice: antitumor therapy by means of interferon-producing cells

1 reference

12 December 2020

Interleukin-12: a recently discovered cytokine with potential for enhancing cell-mediated immune responses to tumors

1 reference

12 December 2020

Human IL-7: a novel T cell growth factor.

1 reference

12 December 2020

Interleukin-1 produced by tumorigenic fibroblasts influences tumor rejection

1 reference

12 December 2020

Decreased tumorigenicity of a transplantable rat sarcoma following transfer and expression of an IL-2 cDNA

1 reference

12 December 2020

Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2

1 reference

12 December 2020

Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

1 reference

12 December 2020

Macrophage activation by granulocyte/macrophage colony-stimulating factor. Priming for enhanced release of tumor necrosis factor-alpha and prostaglandin E2.

1 reference

12 December 2020

Introduction and expression of DNA molecules in eukaryotic cells by electroporation

1 reference

12 December 2020

IFN-beta 2/IL-6 augments the activity of human natural killer cells

1 reference

12 December 2020

Interleukin-2: inception, impact, and implications

1 reference

12 December 2020

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

12 December 2020

In vivo activity of tumor necrosis factor (TNF) mutants. Secretory but not membrane-bound TNF mediates the regression of retrovirally transduced murine tumor

1 reference

12 December 2020

Reduced tumorigenicity of murine tumor cells secreting gamma-interferon is due to nonspecific host responses and is unrelated to class I major histocompatibility complex expression

1 reference

12 December 2020

Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

1 reference

12 December 2020

Vaccinations with tumor cells genetically engineered to produce different cytokines: effectivity not superior to a classical adjuvant

1 reference

12 December 2020

Purified human granulocyte-macrophage colony-stimulating factor: direct action on neutrophils

1 reference

12 December 2020

Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta

1 reference

12 December 2020

Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells

1 reference

12 December 2020

Murine interleukin-4 displays potent anti-tumor activity in vivo

1 reference

12 December 2020

Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer

1 reference

12 December 2020

Concomitant administration of recombinant human interleukin-2 and recombinant interferon alfa-2A: an active outpatient regimen in metastatic renal cell carcinoma

1 reference

12 December 2020

Interleukin 4 (B cell stimulatory factor 1) can mediate the induction of lymphokine-activated killer cell activity directed against fresh tumor cells

1 reference

12 December 2020

There is more than one interleukin 1.

1 reference

12 December 2020

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

1 reference

12 December 2020

Interferon: a cytotoxic T lymphocyte differentiation signal

1 reference

12 December 2020

Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice

1 reference

12 December 2020

Factors affecting the transduction of pluripotent hematopoietic stem cells: long-term expression of a human adenosine deaminase gene in mice.

1 reference

12 December 2020

A new technique for the assay of infectivity of human adenovirus 5 DNA

1 reference

12 December 2020

Immunotherapy of malignancy by in vivo gene transfer into tumors

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02303818

1 reference

Dimensions Publication ID

21 September 2017

1035761894

0 references

Fatcat ID

release_jqp5onqcsbg3tlpqyiizs7twbe

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jqp5onqcsbg3tlpqyiizs7twbe

24 November 2022

mapped directly with Wikidata item

1 reference